Not Yet Recruiting
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
NCT07011589
- Conditions
- Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
- Locations
-
- Stanford University Redwood City, California, United States